Zdrowie i gospodarka · 23/01/2014
FDA Classifies John Cunningham Virus Serological Reagents as Class II Devices
The FDA has classified John Cunningham Virus (JCV) serological reagents as Class II devices, requiring special controls to ensure the device's safety and effectiveness.
Source: Federal Register — Food and Drug AdministrationOpen original release →